SCHEMBL7662902

SCHEMBL7662902

C[C@@H]1CN(C(=O)OC(C)(C)C)C[C@H](C)N1CCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.46
NAMPT P43490 1/20 0.46
BRD4 O60885 3/20 0.45
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
SMARCA2 P51531 1/20 0.42
SMARCA4 P51532 1/20 0.42
PBRM1 Q86U86 1/20 0.42
KCNH2 Q12809 1/20 0.42
SCN5A Q14524 1/20 0.42
SCN9A Q15858 1/20 0.42
KMT2A Q03164 2/20 0.41
PKM P14618 1/20 0.41
HSD17B10 Q99714 2/20 0.40
ACHE P22303 1/20 0.40
RORC P51449 1/20 0.40
GAA P10253 2/20 0.40
IDO1 P14902 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6733246 0.82 TP53 (0.52) TP53KDM4EALDH1A1TDP1KMT2A
SCHEMBL6733250 0.82 TP53 (0.52) TP53KDM4EALDH1A1TDP1KMT2A
SCHEMBL29659287 0.79 KMT2A (0.57) TP53ALDH1A1KMT2AGAA
SCHEMBL578012 0.79 KMT2A (0.57) TP53ALDH1A1KMT2AGAA
SCHEMBL221548 0.79 BRD4 (0.57) TP53NAMPTBRD4KDM4EALDH1A1
SCHEMBL31421325 0.78 BRD4 (0.46) TP53NAMPTBRD4KDM4EKCNH2
SCHEMBL31364933 0.78 HTR1A (0.52) BRD4KMT2AHSD17B10ACHE
SCHEMBL8825578 0.77 ACHE (0.64) BRD4KDM4EPKMACHE
SCHEMBL7985865 0.77 SIGMAR1 (0.50) NAMPTRORC
SCHEMBL7985869 0.77 SIGMAR1 (0.50) NAMPTRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495549-B1 1-HETEROARYL-PIPERIDINE DERIVATIVES; MODERATING NEURONAL DEGENERATION; PROMOTING NEURONAL REGENERATION AND OUTGROWTH; TREATOG NEUROLOGICAL DISORDERS ARISING FROM NEURODEGENERATIVE DISEASES OR OTHER DISORDERS INVOLVING NERVE DAMAGE PFIZER INC 2002-12-17 US disclosed